Area of Research: Targeted Therapy

2022 Grant Recipients

• Pamela Rojas de Santiago, PhD, University of Pennsylvania
  Mentored Investigator Grant
  Investigating the Therapeutic Potential of CRABP2 in HGSOC

2021 Grant Recipients

• Anne M. van Harten, PhD, Thomas Jefferson University
  Mentored Investigator Grant
  Targeted MDM2 Degradation as a Novel Treatment for Ovarian Cancer
• Wei Zhou, PhD, The Wistar Institute
  Mentored Investigator Grant
  Targeting the mevalonate pathway in ARID1A-mutated ovarian cancer

2020 Grant Recipients

• Jianhuang Lin, PhD, The Wistar Institute
  Mentored Investigator Grant
  Targeting ER Stress Pathway in CARM1-Expressing Ovarian Cancer
• Boris Winterhoff, MD, University of Minnesota Twin Cities
  Early Career Investigator Grant
  Precision Medicine in Ovarian Cancer: Using Single Cell Analysis

2018 Grant Recipients

• Goldie Lui, PhD, Fred Hutchinson Cancer Research Center
  Mentored Investigator Grant
  Identifying Novel Targeted Therapies for MYC-driven Ovarian Cancer
• David Sabatini, MD, PhD, Whitehead Institute for Biomedical Research
  Collaborative Research Development Grant
  A Personalized Approach to Identify and Target Ovarian Cancer Liabilities

2017 Grant Recipients

• Ie-Ming Shih, MD, PhD, Johns Hopkins University School of Medicine
  Collaborative Research Development Grant
  Development of Targeted Therapies for Recurrent Ovarian Cancer

2015 Grant Recipients

• Sarah Walker, PhD, Dana Farber Cancer Institute
  Early Career Investigator Grant
  Targeting Transcription Factor Networks for Ovarian Cancer Therapy
• Kris Wood, PhD, Duke University
  Early Career Investigator Grant
  Defining New Combination Therapies for High-grade Serous Ovarian Cancer